Atomistry » Bromine » PDB 6pv8-6ror » 6rby
Atomistry »
  Bromine »
    PDB 6pv8-6ror »
      6rby »

Bromine in PDB 6rby: Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative

Enzymatic activity of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative

All present enzymatic activity of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative:
2.7.1.23;

Protein crystallography data

The structure of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative, PDB code: 6rby was solved by M.Gelin, G.Labesse, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 48.26 / 2.31
Space group I 2 2 2
Cell size a, b, c (Å), α, β, γ (°) 62.096, 76.700, 118.403, 90.00, 90.00, 90.00
R / Rfree (%) 20.4 / 24.3

Bromine Binding Sites:

The binding sites of Bromine atom in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative (pdb code 6rby). This binding sites where shown within 5.0 Angstroms radius around Bromine atom.
In total only one binding site of Bromine was determined in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative, PDB code: 6rby:

Bromine binding site 1 out of 1 in 6rby

Go back to Bromine Binding Sites List in 6rby
Bromine binding site 1 out of 1 in the Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative


Mono view


Stereo pair view

A full contact list of Bromine with other atoms in the Br binding site number 1 of Crystal Structure of Nad Kinase 1 From Listeria Monocytogenes in Complexe with An Adenine Derivative within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Br302

b:88.6
occ:0.60
 BR1 A:JYW302 0.0 88.6 0.6
C2 A:JYW302 1.9 54.7 1.0
N3 A:JYW302 2.9 47.7 1.0
N1 A:JYW302 2.9 49.0 1.0
O A:HOH447 3.0 48.7 1.0
C7 A:JYW302 3.4 54.6 1.0
C6 A:JYW302 3.5 51.0 1.0
CD1 A:LEU49 3.5 63.4 1.0
CB A:ASP45 3.6 40.8 1.0
N A:GLY46 3.8 45.2 1.0
ND2 A:ASN122 3.9 45.8 1.0
C A:ASP45 3.9 43.7 1.0
C3 A:JYW302 4.0 50.4 1.0
C1 A:JYW302 4.0 51.2 1.0
C8 A:JYW302 4.1 64.2 1.0
CA A:GLY46 4.2 35.3 1.0
O A:ASP45 4.3 46.2 1.0
CG A:LEU49 4.3 54.1 1.0
CA A:ASP45 4.4 40.0 1.0
CG A:ASP45 4.8 47.9 1.0
O A:HOH415 4.9 36.5 1.0
CE1 A:HIS223 4.9 56.0 0.5

Reference:

M.Gelin, J.Paoletti, M.A.Nahori, V.Huteau, C.Leseigneur, G.Jouvion, L.Dugue, D.Clement, J.L.Pons, L.Assairi, S.Pochet, G.Labesse, O.Dussurget. From Substrate to Fragments to Inhibitor Activein Vivoagainststaphylococcus Aureus. Acs Infect Dis. 2020.
ISSN: ESSN 2373-8227
PubMed: 32017533
DOI: 10.1021/ACSINFECDIS.9B00368
Page generated: Mon Jul 7 10:19:18 2025

Last articles

Ca in 1FHF
Ca in 1FIC
Ca in 1FID
Ca in 1FIB
Ca in 1FF5
Ca in 1FI6
Ca in 1FI5
Ca in 1FAY
Ca in 1FHY
Ca in 1FHA
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy